Leuprolide: all 151 studies that test it
Page 2 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- GnRH Agonist at Embryo Transfer: IVF OutcomesWithdrawnNCT03544073Phase 3
- CKD-841 Pharmacokinetic/Pharmacodynamic StudyCompletedNCT03233932Phase 1
- Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate CancerStatus unknownNCT03029533Phase 1
- Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast CancerTerminatedNCT02990845Phase 1/2
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide AcetateStatus unknownNCT02974270Phase 4
- Study of Comprehensive Diagnosis and Treatment for Children Precocious PubertyCompletedNCT02920515Phase 4
- Generation of Positive Biological Samples to Leuprolide Acetate for Doping ControlCompletedNCT02920359Phase 1
- Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused UltrasoundWithdrawnNCT02736435Phase 3
- High-Dose Brachytherapy in Treating Patients With Prostate CancerCompletedNCT02346253Not applicable
- Ulipristal vs. GnRHa Prior to Laparoscopic MyomectomyStatus unknownNCT02288130Phase 4
- GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist CyclesStatus unknownNCT02262416Phase 3
- Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst TransfersWithdrawnNCT02238431Not applicable
- Levonorgestrel-releasing Intrauterine System in Patients With EndometriosisCompletedNCT02158845Phase 4
- The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle OutcomesStatus unknownNCT02114645Not applicable
- Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateCompletedNCT02064036Phase 1
- Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.Active, not recruitingNCT01442246Phase 3
- Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen ExcessWithdrawnNCT01422096Early Phase 1
- Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by LeuprolideCompletedNCT01344564Not applicable
- Influence of Male Hormones on Regional Fat MetabolismCompletedNCT01160328Phase 1
- Post-operative or Early Salvage XRT and ADT for High Risk PCaTerminatedNCT00949962Phase 3
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
- Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) PatientsWithdrawnNCT00826839Phase 4
- Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cCompletedNCT00817739Phase 2
- A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.CompletedNCT00776074Phase 2
- Follicle-Stimulating Hormone (FSH) and the Onset of PubertyCompletedNCT00734279Early Phase 1
- Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation TherapyCompletedNCT00684905Phase 2
- Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer PatientsTerminatedNCT00630799Phase 3
- Comparison of Two Pharmacological Treatments of PedophiliaTerminatedNCT00601276Phase 3
- Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate CancerCompletedNCT00598312Phase 3
- RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryCompletedNCT00541047Phase 3
- GnRH Agonist and Antagonists in an Oocyte Donation ProgramCompletedNCT00505817Phase 4
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerTerminatedNCT00498901Phase 2
- The ELDORADO (Eligard®, Docetaxel and Radiotherapy) StudyStatus unknownNCT00452556Phase 2
- PROtecting Ovaries and Fertility During Chemotherapy - The PROOF TrialCompletedNCT00380406Phase 3
- A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARDCompletedNCT00378690Phase 3
- The Use of GnRH Agonist Trigger in the Prevention of OHSSCompletedNCT00349258Phase 4
- Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized TrialTerminatedNCT00243646Phase 3
- Lupron Sex Offender TherapyStatus unknownNCT00220350Phase 2/3
- A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerCompletedNCT00220194Phase 4
- Leuprolide Acetate 3.75 mg Depot to Treat Prostate CancerCompletedNCT00128531Phase 3
- Clinical Trial for Prostate CancerCompletedNCT00076531Phase 3
- Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 StudyCompletedNCT00076440Phase 2
- ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigationCompletedNCT00063310Phase 2
- Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate CancerCompletedNCT00056654Not applicable
- Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron DiseaseCompletedNCT00004771Phase 2
- Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian HyperandrogenismCompletedNCT00004763Phase 2
- Leuprolide in Treating Adults With HypogonadotropismCompletedNCT00004438Not applicable
- Leuprolide in Determining the Cause of Gonadotropin DeficiencyCompletedNCT00004426Not applicable
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans SyndromeCompletedNCT00004311Phase 2
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerCompletedNCT00003653Phase 3